Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2025International Journal of Dermatology

Clinicodemographic Features and Usage of Oral Immunosuppressive Agents in Childhood and Adolescent Vitiligo: Retrospective Chart Review From a Tertiary Care Centre in Northern India

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMuthu Sendhil KumaranSSSukhdeep SinghKVKeshavamurthy Vinay

Discussion

Loading...

Member takes

Overview

Retrospective chart review reveals immunosuppressive agents improve disease stabilization in pediatric vitiligo, suggesting a need for tailored treatments.

Key Points

  • Systemic immunosuppressive agents exhibit efficacy in stabilizing pediatric vitiligo with manageable side effects.
  • Among 304 patients, disease stabilization was achieved in 63.6% after oral mini-pulse therapy.
  • Tofacitinib showed the highest rate of disease control at 88.9%, while methotrexate and azathioprine had lower rates.
  • This research highlights the importance of early intervention and tailored treatment strategies for better outcomes.

Cite This Study

Kumaran et al. (2025) studied this question.

synapsesocial.com/papers/689a0933e6551bb0af8ce5aahttps://doi.org/10.1111/ijd.17978
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinico-Epidemiological Profile of Childhood Vitiligo2024 · 2 citations
  2. 2Clinical Characteristics and Treatment Patterns in Patients With Vitiligo2026
  3. 3Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo2026
  4. 4Exploring the spectrum of vitiligo: Clinical and demographic perspectives – A cross-sectional study2024 · 5 citations
  5. 5Efficacy and Safety of Small Molecule Inhibitor Therapies for Vitiligo: A Systematic Review2026